Glenmark Pharmaceuticals Limited has announced an interim dividend for the financial year 2025-26. In a board meeting held on Friday, 26th September 2025, the company approved an interim dividend of ₹2.50 per equity share (face value ₹1 each), amounting to approximately ₹705.50 million.
The record date for dividend eligibility is set for Friday, 3rd October 2025. Shareholders registered as of this date will receive the dividend, which will be paid within 30 days from the date of declaration.
In the exchagne filings, the company shared, “The Board of Directors of the Company, has considered and approved the Interim Dividend of ~ 2.50 per equity shares on face value of ~ 1/- per equity shares for the Financial Year 2025-26 amounting to~ 705.50 millions. As intimated earlier on 22nd September 2025, the record date for the purpose of payment of dividend shall be Friday, 3rd October, 2025, and the interim dividend will be paid within 30 days from the date of the declaration.”
